Human polyomavirus JC small regulatory agnoprotein forms highly stable dimers and oligomers: Implications for their roles in agnoprotein function

Virology

Volumn 420, Issue 1, 2011, Pages 51-65

  Saribas, A Sami ^a   Arachea, Buenafe T ^b   White, Martyn K ^a   Viola, Ronald E ^b   Safak, Mahmut ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

Agnoprotein; BKV; JC virus; Oligomer; PML; Replication; Stable dimer; SV40; Transcription

Indexed keywords

AGNOPROTEIN; AMINO ACID; DIMER; HOMODIMER; OLIGOMER; UREA; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VIVO STUDY; JC VIRUS; MASS SPECTROMETRY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CELL LINE; DIMERIZATION; HUMANS; JC VIRUS; MOLECULAR SEQUENCE DATA; POLYOMAVIRUS INFECTIONS; PROTEIN STABILITY; TUMOR VIRUS INFECTIONS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

BK POLYOMAVIRUS; JC POLYOMAVIRUS;

EID: 80053386766     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.08.015     Document Type: Article

References (72)

1. Akan I., Sariyer I.K., Biffi R., Palermo V., Woolridge S., White M.K., Amini S., Khalili K., Safak M. Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology 2006, 349(1):66-78.
2. Alwine J.C. Evidence for simian virus 40 late transcriptional control: mixed infections of wild-type simian virus 40 and a late leader deletion mutant exhibit trans effects on late viral RNA synthesis. J. Virol. 1982, 42(3):798-803.
3. Auborn K.J., Markowitz R.B., Wang E., Yu Y.T., Prives C. Simian virus 40 (SV40) T antigen binds specifically to double-stranded DNA but not to single-stranded DNA or DNA/RNA hybrids containing the SV40 regulatory sequences. J. Virol. 1988, 62(6):2204-2208.
4. Bollag B., Kilpatrick L.H., Tyagarajan S.K., Tevethia M.J., Frisque R.J. JC virus T'135, T'136 and T'165 proteins interact with cellular p107 and p130 in vivo and influence viral transformation potential. J. Neurovirol. 2006, 12(6):428-442.
5. Bollag B., Hofstetter C.A., Reviriego-Mendoza M.M., Frisque R.J. JC virus small T antigen binds phosphatase PP2A and Rb family proteins and is required for efficient viral DNA replication activity. PLoS One 2010, 5(5):e10606.
6. Bolton D.L., Lenardo M.J. Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells. J. Virol. 2007, 81(17):8878-8890.
7. Bourbigot S., Beltz H., Denis J., Morellet N., Roques B.P., Mely Y., Bouaziz S. The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain. Biochem. J. 2005, 387(Pt 2):333-341.
8. Cui J., Tungaturthi P.K., Ayyavoo V., Ghafouri M., Ariga H., Khalili K., Srinivasan A., Amini S., Sawaya B.E. The role of Vpr in the regulation of HIV-1 gene expression. Cell Cycle 2006, 5(22):2626-2638.
9. Cullen B. HIV-1 auxiliary proteins: making connections in dying cell. Cell 1998, 93:685-692.
10. Cullen B.R. Retroviruses as model systems for the study of nuclear RNA export pathways. Virology 1998, 249(2):203-210.
11. Cullen B.R. Nuclear mRNA export: insights from virology. Trends Biochem. Sci. 2003, 28(8):419-424.
12. Cullen B.R. Nuclear RNA export. J. Cell Sci. 2003, 116(Pt 4):587-597.
13. Darbinyan A., Darbinian N., Safak M., Radhakrishnan S., Giordano A., Khalili K. Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene 2002, 21(36):5574-5581.
14. Daugherty M.D., D'Orso I., Frankel A.D. A solution to limited genomic capacity: using adaptable binding surfaces to assemble the functional HIV Rev oligomer on RNA. Mol. Cell 2008, 31(6):824-834.
15. Daugherty M.D., Booth D.S., Jayaraman B., Cheng Y., Frankel A.D. HIV Rev response element (RRE) directs assembly of the Rev homooligomer into discrete asymmetric complexes. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(28):12481-12486.
16. Daugherty M.D., Liu B., Frankel A.D. Structural basis for cooperative RNA binding and export complex assembly by HIV Rev. Nat. Struct. Mol. Biol. 2010, 17(11):1337-1342.
17. Del Valle L., Gordon J., Enam S., Delbue S., Croul S., Abraham S., Radhakrishnan S., Assimakopoulou M., Katsetos C.D., Khalili K. Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J. Natl. Cancer Inst. 2002, 94(4):267-273.
18. DiMattia M.A., Watts N.R., Stahl S.J., Rader C., Wingfield P.T., Stuart D.I., Steven A.C., Grimes J.M. Implications of the HIV-1 Rev dimer structure at 3.2A resolution for multimeric binding to the Rev response element. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(13):5810-5814.
19. Ducret A., Bartone N., Haynes P.A., Blanchard A., Aebersold R. A simplified gradient solvent delivery system for capillary liquid chromatography-electrospray ionization mass spectrometry. Anal. Biochem. 1998, 265(1):129-138.
20. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997, 90(6):1051-1060.
21. Frankel A.D., Bredt D.S., Pabo C.O. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 1988, 240(4848):70-73.
22. Frankel A.D., Chen L., Cotter R.J., Pabo C.O. Dimerization of the tat protein from human immunodeficiency virus: a cysteine-rich peptide mimics the normal metal-linked dimer interface. Proc. Natl. Acad. Sci. U.S.A. 1988, 85(17):6297-6300.
23. Frisque R.J., White F.A. The molecular biology of JC virus, causative agent of progressive multifocal leukoencophalopathy. Molecular Neurovirology, pathogenesis of viral CNS infections 1992, 25-158. Humana Press Inc., Totowa, NJ. R.P. Roose (Ed.).
24. Fritz J.V., Didier P., Clamme J.P., Schaub E., Muriaux D., Cabanne C., Morellet N., Bouaziz S., Darlix J.L., Mely Y., de Rocquigny H. Direct Vpr-Vpr interaction in cells monitored by two photon fluorescence correlation spectroscopy and fluorescence lifetime imaging. Retrovirology 2008, 5:87.
25. Fritz J.V., Dujardin D., Godet J., Didier P., De Mey J., Darlix J.L., Mely Y., de Rocquigny H. HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag. J. Virol. 2010, 84(3):1585-1596.
26. Gilbert J., Nomura S., Anderson C.W., George K. Identification of the SV40 agnoproduct: a DNA binding protein. Nature 1981, 291:346-349.
27. Godet A.N., Guergnon J., Croset A., Cayla X., Falanga P.B., Colle J.H., Garcia A. PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins. PLoS One 2010, 5(11):e13760.
28. Haggerty S., Walker D.L., Frisque R.J. JC virus-simian virus 40 genomes containing heterologous regulatory signals and chimeric early regions: identification of regions restricting transformation by JC virus. J. Virol. 1989, 63(5):2180-2190.
29. Hartlieb B., Modrof J., Muhlberger E., Klenk H.D., Becker S. Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. J. Biol. Chem. 2003, 278(43):41830-41836.
30. Hay N., Skolnik-David H., Aloni Y. Attenuation in the control of SV40 gene expression. Cell 1982, 29(1):183-193.
31. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 1967, 26(2):365-369.
32. Hock M., Kraus I., Schoehn G., Jamin M., Andrei-Selmer C., Garten W., Weissenhorn W. RNA induced polymerization of the Borna disease virus nucleoprotein. Virology 2010, 397(1):64-72.
33. Hou-Jong M.H., Larsen S.H., Roman A. Role of the agnoprotein in regulation of simian virus 40 replication and maturation pathways. J. Virol. 1987, 61(3):937-939.
34. Iordanskiy S., Zhao Y., DiMarzio P., Agostini I., Dubrovsky L., Bukrinsky M. Heat-shock protein 70 exerts opposing effects on Vpr-dependent and Vpr-independent HIV-1 replication in macrophages. Blood 2004, 104(6):1867-1872.
35. Johannessen M., Myhre M.R., Dragset M., Tummler C., Moens U. Phosphorylation of human polyomavirus BK agnoprotein at Ser-11 is mediated by PKC and has an important regulative function. Virology 2008, 379(1):97-109.
36. Khalili K., White M.K., Sawa H., Nagashima K., Safak M. The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. J. Cell. Physiol. 2005, 204(1):1-7.
37. Khalili K., Sariyer I.K., Safak M. Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation. J. Cell. Physiol. 2008, 215(2):309-319.
38. Kolodziejski P.J., Rashid M.B., Eissa N.T. Intracellular formation of "undisruptable" dimers of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(24):14263-14268.
39. Kwak Y.T., Raney A., Kuo L.S., Denial S.J., Temple B.R., Garcia J.V., Foster J.L. Self-association of the Lentivirus protein. Nef. Retrovirology 2010, 7:77.
40. Lynch K.J., Frisque R.J. Identification of critical elements within the JC virus DNA replication origin. J. Virol. 1990, 64(12):5812-5822.
41. Lynch K.J., Haggerty S., Frisque R.J. DNA replication of chimeric JC virus-simian virus 40 genomes. Virology 1994, 204(2):819-822.
42. Major E.O., Miller A.E., Mourrain P., Traub R.G., de Widt E., Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl. Acad. Sci. U.S.A. 1985, 82(4):1257-1261.
43. Major E.O., Amemiya K., Tornatore C.S., Houff S.A., Berger J.R. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin. Microbiol. Rev. 1992, 5(1):49-73.
44. Margolskee R.F., Nathans D. Suppression of a VP1 mutant of simian virus 40 by missense mutations in serine codons of the viral agnogene. J. Virol. 1983, 48(2):405-409.
45. Marianayagam N.J., Sunde M., Matthews J.M. The power of two: protein dimerization in biology. Trends Biochem. Sci. 2004, 29(11):618-625.
46. Merabova N., Kaniowska D., Kaminski R., Deshmane S.L., White M.K., Amini S., Darbinyan A., Khalili K. JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis. J. Virol. 2008, 82(3):1558-1569.
47. Myhre M.R., Olsen G.H., Gosert R., Hirsch H.H., Rinaldo C.H. Clinical polyomavirus BK variants with agnogene deletion are non-functional but rescued by trans-complementation. Virology 2010, 398(1):12-20.
48. Ng S.C., Behm M., Bina M. DNA sequence alterations responsible for the synthesis of thermosensitive VP1 in temperature-sensitive BC mutants of simian virus 40. J. Virol. 1985, 54(2):646-649.
49. Ng S.C., Mertz J.E., Sanden-Will S., Bina M. Simian virus 40 maturation in cells harboring mutants deleted in the agnogene. J. Biol. Chem. 1985, 260(2):1127-1132.
50. Nomura S., Khoury G., Jay G. Subcellular localization of the simian virus 40 agnoprotein. J. Virol. 1983, 45(1):428-433.
51. Okada Y., Sawa H., Endo S., Orba Y., Umemura T., Nishihara H., Stan A.C., Tanaka S., Takahashi H., Nagashima K. Expression of JC virus agnoprotein in progressive multifocal leukoencephalopathy brain. Acta Neuropathol. 2002, 104(2):130-136.
52. Okada Y., Suzuki T., Sunden Y., Orba Y., Kose S., Imamoto N., Takahashi H., Tanaka S., Hall W.W., Nagashima K., Sawa H. Dissociation of heterochromatin protein 1 from lamin B receptor induced by human polyomavirus agnoprotein: role in nuclear egress of viral particles. EMBO Rep. 2005, 6(5):452-457.
53. Pollard V.W., Malim M.H. The HIV-1 Rev protein. Annu. Rev. Microbiol. 1998, 52:491-532.
54. Poon B., Chang M.A., Chen I.S. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA. J. Virol. 2007, 81(19):10515-10523.
55. Rinaldo C.H., Traavik T., Hey A. The agnogene of the human polyomavirus BK is expressed. J. Virol. 1998, 72(7):6233-6236.
56. Roy A., Kucukural A., Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 2010, 5(4):725-738.
57. Safak M., Barrucco R., Darbinyan A., Okada Y., Nagashima K., Khalili K. Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J. Virol. 2001, 75(3):1476-1486.
58. Safak M., Sadowska B., Barrucco R., Khalili K. Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J. Virol. 2002, 76(8):3828-3838.
59. Sariyer I.K., Akan I., Palermo V., Gordon J., Khalili K., Safak M. Phosphorylation mutants of JC virus agnoprotein are unable to sustain the viral infection cycle. J. Virol. 2006, 80(8):3893-3903.
60. Sariyer I.K., Khalili K., Safak M. Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen. Virology 2008, 375(2):464-479.
61. Sariyer I.K., Saribas A.S., White M.K., Safak M. Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content. Virol. J. 2011, 8(1):255.
62. Serpell L.C., Sunde M., Blake C.C. The molecular basis of amyloidosis. Cell. Mol. Life Sci. 1997, 53(11-12):871-887.
63. Simmons D.T., Loeber G., Tegtmeyer P. Four major sequence elements of simian virus 40 large T antigen coordinate its specific and nonspecific DNA binding. J. Virol. 1990, 64(5):1973-1983.
64. Sunde M., Blake C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 1997, 50:123-159.
65. Sunde M., Serpell L.C., Bartlam M., Fraser P.E., Pepys M.B., Blake C.C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 1997, 273(3):729-739.
66. Suzuki T., Okada Y., Semba S., Orba Y., Yamanouchi S., Endo S., Tanaka S., Fujita T., Kuroda S., Nagashima K., Sawa H. Identification of FEZ1 as a protein that interacts with JC virus agnoprotein and microtubules: role of agnoprotein-induced dissociation of FEZ1 from microtubules in viral propagation. J. Biol. Chem. 2005, 280(26):24948-24956.
67. Suzuki T., Orba Y., Okada Y., Sunden Y., Kimura T., Tanaka S., Nagashima K., Hall W.W., Sawa H. The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathog. 2010, 6(3):e1000801.
68. Unterstab G., Gosert R., Leuenberger D., Lorentz P., Rinaldo C.H., Hirsch H.H. The polyomavirus BK agnoprotein co-localizes with lipid droplets. Virology 2010, 399(2):322-331.
69. Venkatachari N.J., Walker L.A., Tastan O., Le T., Dempsey T.M., Li Y., Yanamala N., Srinivasan A., Klein-Seetharaman J., Montelaro R.C., Ayyavoo V. Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles. Virol. J. 2010, 7:119.
70. Yang S., Sun Y., Zhang H. The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle. J. Biol. Chem. 2001, 276(7):4889-4893.
71. Zhao L.J., Wang L., Mukherjee S., Narayan O. Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. J. Biol. Chem. 1994, 269(51):32131-32137.
72. Ziegler K., Bui T., Frisque R.J., Grandinetti A., Nerurkar V.R. A rapid in vitro polyomavirus DNA replication assay. J. Virol. Methods 2004, 122(1):123-127.